Organized by Masamitsu Maekawa and Liao Hsiao-Wei.
Mass spectrometry has been used in chemical diagnosis of diseases due to its usefulness in measuring various biomolecules. Furthermore, it has also been put to good use in the quantitative analysis of pharmaceuticals in recent years, and is contributing to more precise medical care. In addition, many new studies of pathological molecular mechanisms have been discovered through reverse translational research based on the results of clinical research. The aim of this session is to discuss the frontier of clinical mass spectrometry in chemical diagnosis and optimization of patient treatment, as well as in reverse translational research.